Design Therapeutics Inc
(NAS:DSGN)
$
4.52
-0.555 (-10.94%)
Market Cap: 255.93 Mil
Enterprise Value: 4.38 Mil
PE Ratio: 0
PB Ratio: 1.01
GF Score: 34/100 Design Therapeutics Inc at Jefferies Cell and Genetic Medicine Summit Transcript
Sep 29, 2022 / 02:00PM GMT
Release Date Price:
$16.79
(-4.17%)
Adam Carlson
(Trades, Portfolio) LLC - Analyst
Hi, everyone. Thank you for coming to the presentation for Design Therapeutics. I'm Adam Carlson. I'm a Vice President in the group here at Jefferies, working closely with the company.
Today, Sean Jefferies, COO, is going to be going through the presentation for us. And we've definitely left a little bit of time at the end for some Q&A. So if you have questions, feel free. We can have a bit of back and forth at the end. Sean.
Sean Jeffries
Design Therapeutics, Inc. - COO
Thank you, Adam. And thank you to Jefferies for the opportunity to tell the Design story.
Before I get started, I should say that this presentation contains forward-looking statements identified by the words such as those
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot